Effects of Emotional Intelligence Training on Marital Satisfaction and Mental Health Among Married People in Dhaka City

May 24, 2026 updated by: Nusrat Sharmin, University of Dhaka

This study aims to examine the effects of Emotional Intelligence (EI) training on marital satisfaction and mental health among married adults in Dhaka city, Bangladesh. Emotional intelligence refers to the ability to recognize, understand, regulate, and manage emotions in oneself and others. Previous studies suggest that emotional intelligence is associated with better relationship quality and psychological well-being; however, limited intervention-based evidence is available in Bangladesh.

A pretest-posttest quasi-experimental design with intervention and control groups will be used. Married adults living in Dhaka City will be assessed on emotional intelligence, marital satisfaction, anxiety, depression, and mental well-being at baseline. Participants with lower emotional intelligence scores based on the baseline TEIQue-SF assessment will be selected for the intervention phase.

The intervention group will receive a structured emotional intelligence training program focusing on emotional awareness, emotion regulation, empathy, communication skills, and interpersonal problem-solving. Assessments will be conducted at baseline, post-intervention, and follow-up to evaluate changes in marital satisfaction and mental health outcomes.

The findings are expected to provide evidence regarding the effectiveness of emotional intelligence training as a low-cost, non-clinical intervention for improving marital relationships and psychological well-being among married individuals in Bangladesh.

Study Overview

Status

Status

Indicates the current recruitment status or the expanded access status.
Not yet recruiting

Conditions

Conditions

The disease, disorder, syndrome, illness, or injury that is being studied. On ClinicalTrials.gov, conditions may also include other health-related issues, such as lifespan, quality of life, and health risks.

Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.

Detailed Description

Background

Marital dissatisfaction, emotional distress, anxiety, and depression are increasingly recognized as important public health concerns affecting individual and family well-being. Emotional intelligence has been identified as a potential factor associated with healthier interpersonal relationships, improved emotional regulation, and better psychological adjustment. Previous research has shown associations between emotional intelligence, marital satisfaction, and mental health outcomes. However, limited intervention-based research has examined whether emotional intelligence training can improve marital satisfaction and mental health among married adults in Bangladesh.

Purpose of the Study

The purpose of this study is to evaluate the effectiveness of an emotional intelligence training program on marital satisfaction and mental health among married individuals living in Dhaka City.

Study Design

The study will use a pretest-posttest quasi-experimental design with intervention and control groups. Assessments will be conducted at three time points: baseline assessment, post-intervention assessment, and follow-up assessment. The interval between baseline and post-intervention assessments will be at least four weeks, and the follow-up assessment will be conducted three months after completion of the intervention.

Participants and Sampling

The target population will include married men and women residing in Dhaka city. Participants will be recruited using convenience sampling.

Inclusion criteria will include:

Married for at least two years Living with spouse Living in a nuclear family Age between 20 and 60 years Ability to read and write Bangla Willingness to participate in the study

Exclusion criteria will include:

Presence of severe physical illness Incomplete assessment responses

Participants with lower emotional intelligence scores based on the baseline TEIQue-SF assessment will be selected. Approximately the lowest 40% of scorers from the baseline sample will be included in the intervention phase and randomly assigned to intervention and control groups.

A total sample size of 120 participants is planned, with 60 participants in the intervention group and 60 participants in the control group.

Intervention

The intervention group will receive a structured emotional intelligence training program designed to improve emotional awareness, emotional regulation, empathy, interpersonal communication, and coping skills. Training sessions will include psychoeducation, group discussion, practical exercises, and real-life applications related to emotional functioning and marital relationships.

The control group will not receive the full intervention during the study period. After completion of the post-test assessment, the control group will receive a one-day workshop on emotional intelligence.

Outcome Measures

The study will assess emotional intelligence, marital satisfaction, anxiety, depression, and psychological well-being using standardized self-report instruments.

The following measures will be used:

Trait Emotional Intelligence Questionnaire-Short Form (TEIQue-SF) ENRICH Marital Satisfaction Scale (EMS) Beck Anxiety Inventory (BAI) Beck Depression Inventory-II (BDI-II) Mental Health Continuum-Short Form (MHC-SF)

Socio-demographic information including age, gender, education, occupation, socioeconomic status, and number of children will also be collected.

Procedure

Eligible participants will receive information regarding the purpose and procedures of the study before providing informed consent. Baseline assessments will be conducted prior to group allocation.

Participants with lower emotional intelligence scores based on the baseline TEIQue-SF assessment will be selected. Approximately the lowest 40% of scorers from the baseline sample will be included in the intervention phase and randomly assigned to intervention and control groups. The intervention group will participate in the emotional intelligence training program, while the control group will continue usual daily activities during the intervention period.

Post-intervention and follow-up assessments will be conducted using the same measures administered at baseline.

Data Analysis

Data analysis will be conducted using SPSS and R statistical software. Descriptive statistics will be calculated for socio-demographic and study variables. Baseline differences between groups will be examined using independent sample t-tests. Pearson correlation analysis will be conducted to examine relationships among study variables.

Multivariate analysis of covariance (MANCOVA) will be used to evaluate intervention effects on marital satisfaction and mental health outcomes while controlling for baseline scores. Repeated measures analysis will be conducted to examine changes across assessment time points and evaluate maintenance of intervention effects over time.

Expected Significance

The study is expected to contribute evidence regarding the effectiveness of emotional intelligence training for improving marital satisfaction and mental health among married adults in Bangladesh. The findings may support the development of preventive mental health interventions, relationship enhancement programs, and family well-being initiatives in community and clinical settings.

Study Type

Study Type

Describes the nature of a clinical study. Study types include interventional studies (also called clinical trials), observational studies (including patient registries), and expanded access.
Interventional

Enrollment (Estimated)

Enrollment

The number of participants in a clinical study. The "anticipated" enrollment is the target number of participants that the researchers need for the study.
120

Phase

Phase

The stage of a clinical trial studying a drug or biological product, based on definitions developed by the U.S. Food and Drug Administration (FDA). The phase is based on the study's objective, the number of participants, and other characteristics. There are five phases: Early Phase 1 (formerly listed as Phase 0), Phase 1, Phase 2, Phase 3, and Phase 4. Not Applicable is used to describe trials without FDA-defined phases, including trials of devices or behavioral interventions.
  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact

The name and contact information for the person who can answer enrollment questions for a clinical study. Each location where the study is being conducted may also have a specific contact, who may be better able to answer those questions.

Study Contact Backup

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Eligibility Criteria

The key requirements that people who want to participate in a clinical study must meet or the characteristics they must have. Eligibility criteria consist of both inclusion criteria (which are required for a person to participate in the study) and exclusion criteria (which prevent a person from participating). Types of eligibility criteria include whether a study accepts healthy volunteers, has age or age group requirements, or is limited by sex.

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  1. Married men and women living in Dhaka city
  2. Age between 20 and 40 years
  3. Married for at least 2 years and living with spouse
  4. Living in a nuclear family
  5. Able to read and write (literate)
  6. Willing to participate and provide informed consent

Exclusion Criteria:

  1. Individuals with self-reported severe physical illness
  2. Individuals with incomplete questionnaire responses
  3. Individuals unwilling to participate or unable to provide informed consent

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm

Participant Group / Arm

A group or subgroup of participants in a clinical trial that receives a specific intervention/treatment, or no intervention, according to the trial's protocol.
Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.
Experimental: Emotional Intelligence Training Group
Participants in this arm will receive a structured Emotional Intelligence training program designed to improve emotional awareness, emotional regulation, empathy, stress management, and interpersonal communication skills through multiple interactive sessions including psychoeducation, group discussion, role-play, and practical exercises.
Behavioral: Emotional Intelligence Training
Participants in this arm will receive a structured Emotional Intelligence (EI) training program designed to enhance emotional awareness, emotional regulation, empathy, stress management, and interpersonal communication skills. The training will be delivered through multiple sessions involving psychoeducation, group discussions, role-playing, and practical exercises. The aim of the intervention is to improve emotional intelligence, marital satisfaction, and mental health outcomes among married adults.
No Intervention: Control Group
Participants in this arm will not receive the Emotional Intelligence training during the study period. They will continue their usual daily activities without any structured psychological intervention. After completion of post-intervention assessments, a brief emotional intelligence workshop will be offered to participants in the control group.

What is the study measuring?

Primary Outcome Measures

Primary Outcome Measures

In a clinical study's protocol, the planned outcome measure that is the most important for evaluating the effect of an intervention/treatment. Most clinical studies have one primary outcome measure, but some have more than one.
Outcome Measure
Measure Description
Time Frame
Marital Satisfaction
Time Frame: Baseline, 4 weeks (post-test), and 3-month follow-up
Marital satisfaction will be assessed using the Marital Satisfaction subscale of the ENRICH Marital Satisfaction Scale (EMS). The subscale consists of 10 items rated on a 5-point Likert scale. Total scores range from 10 to 50, with higher scores indicating greater marital satisfaction.
Baseline, 4 weeks (post-test), and 3-month follow-up
Depression
Time Frame: Baseline, 4 weeks (post-test), and 3-month follow-up
Depression will be measured using the Beck Depression Inventory-II (BDI-II), a 21-item standardized self-report scale assessing severity of depressive symptoms. Total scores range from 0 to 63, with higher scores indicating more severe depressive symptoms and worse mental health outcomes.
Baseline, 4 weeks (post-test), and 3-month follow-up
Anxiety
Time Frame: Baseline, 4 weeks (post-test), and 3-month follow-up
Anxiety will be assessed using the Beck Anxiety Inventory (BAI), a 21-item standardized self-report instrument measuring severity of anxiety symptoms. Total scores range from 0 to 63, with higher scores indicating greater anxiety severity and worse mental health outcomes.
Baseline, 4 weeks (post-test), and 3-month follow-up
Psychological Well-being
Time Frame: Baseline, 4 weeks (post-test), and 3-month follow-up
Psychological well-being will be assessed using the Mental Health Continuum-Short Form (MHC-SF), which measures emotional, psychological, and social well-being. Total scores range from 0 to 70, with higher scores indicating greater psychological well-being and better mental health outcomes.
Baseline, 4 weeks (post-test), and 3-month follow-up

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Sponsor

The organization or person who initiates the study and who has authority and control over the study.
University of Dhaka

Investigators

Investigators

A researcher involved in a clinical study. Related terms include site principal investigator, site sub-investigator, study chair, study director, and study principal investigator.
  • Principal Investigator: Nusrat Sharmin, MSc, PhD candidate, Department of Psychology, University of Dhaka

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

Study Start

The actual date on which the first participant was enrolled in a clinical study. The "anticipated" study start date is the date that the researchers think will be the study start date.
July 1, 2026

Primary Completion (Estimated)

Primary Completion

The date on which the last participant in a clinical study was examined or received an intervention to collect final data for the primary outcome measure. Whether the clinical study ended according to the protocol or was terminated does not affect this date. For clinical studies with more than one primary outcome measure with different completion dates, this term refers to the date on which data collection is completed for all the primary outcome measures. The "anticipated" primary completion date is the date that the researchers think will be the primary completion date for the study.
November 30, 2026

Study Completion (Estimated)

Study Completion

The date on which the last participant in a clinical study was examined or received an intervention/treatment to collect final data for the primary outcome measures, secondary outcome measures, and adverse events (that is, the last participant's last visit). The "anticipated" study completion date is the date that the researchers think will be the study completion date.
January 31, 2027

Study Registration Dates

First Submitted

First Submitted

The date on which the study sponsor or investigator first submitted a study record to ClinicalTrials.gov. There is typically a delay of a few days between the first submitted date and the record's availability on ClinicalTrials.gov (the first posted date).
May 2, 2026

First Submitted That Met QC Criteria

First Submitted That Met QC Criteria

The date on which the study sponsor or investigator first submits a study record that is consistent with National Library of Medicine (NLM) quality control (QC) review criteria. The sponsor or investigator may need to revise and submit a study record one or more times before NLM's QC review criteria are met. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
May 15, 2026

First Posted (Actual)

First Posted

The date on which the study record was first available on ClinicalTrials.gov after National Library of Medicine (NLM) quality control (QC) review has concluded. There is typically a delay of a few days between the date the study sponsor or investigator submitted the study record and the first posted date.
May 22, 2026

Study Record Updates

Last Update Posted (Actual)

Last Update Posted

The most recent date on which changes to a study record were made available on ClinicalTrials.gov. There may be a delay between when the changes were submitted to ClinicalTrials.gov by the study's sponsor or investigator (the last update submitted date) and the last update posted date.
May 28, 2026

Last Update Submitted That Met QC Criteria

Last Update Submitted That Met QC Criteria

The most recent date on which the study sponsor or investigator submitted changes to a study record that are consistent with National Library of Medicine (NLM) quality control (QC) review criteria. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
May 24, 2026

Last Verified

Last Verified

The most recent date on which the study sponsor or investigator confirmed the information about a clinical study on ClinicalTrials.gov as accurate and current. If a study with a recruitment status of recruiting; not yet recruiting; or active, not recruiting has not been confirmed within the past 2 years, the study's recruitment status is shown as unknown.
May 1, 2026

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

Other Study ID Numbers

Identifiers or ID numbers other than the NCT number that are assigned to a clinical study by the study's sponsor, funders, or others. These numbers may include unique identifiers from other trial registries and National Institutes of Health grant numbers.
  • DU_EI_MaritalStudy_01
  • 37.01.0000.000.071.36.0006.23 (Other Grant/Funding Number: University Grants Commission of Bangladesh)
  • Ref. No.230/Biol.Scs. (Other Identifier: Faculty of Biological Sciences, University of Dhaka)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

Individual participant data (IPD) will not be shared publicly due to ethical and confidentiality concerns. The study involves sensitive personal and psychological information related to marital satisfaction, emotional intelligence, and mental health. To protect participant privacy and ensure confidentiality, only aggregate results will be reported in publications and presentations. Data access will be restricted to the research team only.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Mental Health

Clinical Trials on Emotional Intelligence Training

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Cookie Settings

We use cookies to ensure that we give you the best experience on our website. For more details carefully read our Privacy and Cookies Policy. ...>>>You can change your preferences or withdraw your consent at any time by deleting the cookies from your website or computer as described in the policy. Please accept it and choose your preferences by ticking the corresponding boxes in the "Manage Settings" section below. Please carefully read our Terms of Service before you proceed with using any part of this website.
«Manage Settings